Underwriters Shouldn't Be Reading Lab Reports
Underwriters Shouldn't Be Reading Lab Reports The Manual COA Problem Is Becoming One of the Biggest Compliance Gaps in Regulated Payment...
The U.S. Senate has rejected an amendment that would have removed sweeping hemp THC ban language from a key government spending bill, signaling that federal recriminalization of many hemp-derived products is moving forward. The vote deepens uncertainty for hemp businesses and accelerates the need for rigorous compliance, documentation, and risk planning.
On November 11, 2025, senators voted 76–24 to table an amendment from Senator Rand Paul that aimed to strip hemp ban provisions from a short-term funding bill to end the federal shutdown. The motion to table was made by Senator Mitch McConnell, who also championed the restrictive hemp language now embedded in the package.
By rejecting Paul’s amendment, the Senate kept intact language that would dramatically narrow the federal definition of legal hemp and effectively outlaw most intoxicating hemp-derived THC products, including many edibles, beverages, and vapes that emerged after the 2018 Farm Bill.
The bill now moves to the House of Representatives as part of the broader deal to reopen the government. President Donald Trump has already signaled support for closing the hemp “loophole,” despite having signed the 2018 Farm Bill that legalized hemp and its derivatives.
Under current law, hemp is legal if it contains less than 0.3 percent delta-9 THC by dry weight. The new language would tighten that standard in several ways:
Measure “total THC,” not just delta-9, capturing delta-8, other isomers, and THCA.
Limit legal hemp products to a maximum of 0.4 milligrams of total THC (and similar intoxicating cannabinoids) per container.
Ban “intermediate hemp-derived cannabinoid products” marketed directly to consumers.
Exclude cannabinoids that cannot be naturally produced by the cannabis plant, or that are synthesized outside it.
In practice, this framework would eliminate most hemp-derived intoxicating products and likely sweep many currently legal CBD and minor-cannabinoid products into a de facto prohibition if they exceed the new total-THC limit. Hemp industry advocates warn it could “destroy” large portions of the sector and nullify several state-level regulatory models.
The debate has split traditional allies and sharpened divides inside the Republican Party.
Senator Rand Paul and hemp trade groups argue the language will close businesses, erase jobs, and override state rules that already regulate hemp intoxicants. Senator Mitch McConnell and other supporters say the provision is needed to curb unregulated intoxicating hemp products and protect youth, while preserving industrial hemp and non-intoxicating CBD uses.
Outside Congress, powerful interests are also weighing in:
National alcohol trade groups, including distilled spirits and beer associations, have urged senators to keep the ban language, arguing for clearer federal rules on hemp THC.
Lawyers representing hemp beverage companies have warned Congress that the proposal is “overbroad” and “disastrous,” threatening an emerging category of functional beverages many retailers now rely on.
If the language becomes law, companies built around hemp-derived THC will face a short runway to adapt business models, reformulate products, or exit the category altogether. National and regional brands that have leaned into hemp beverages, gummies, seltzers, and vapes will need to evaluate:
Product portfolios against total-THC caps.
State-level rules that may soon conflict with tighter federal limits.
Contract terms with suppliers, retailers, and investors premised on the 2018 Farm Bill framework.
For regulated cannabis operators, the shift could redirect demand away from hemp-derived intoxicants and back into licensed marijuana channels. But it also raises new expectations around documentation, testing, and proof of legal status for any product with THC or related cannabinoids.
In this environment, “good faith” is not enough. Businesses will need verifiable, third-party evidence that products and operations comply with evolving definitions of hemp and cannabis.
The Senate’s rejection of the amendment is a clear signal: federal tolerance for hemp-derived THC sold in gray areas is ending. Operators in both hemp and cannabis must treat this as a compliance turning point.
That means strengthening:
Documented compliance frameworks and governance.
End-to-end traceability for cannabinoids across the supply chain.
Tamper-proof Certificates of Analysis and product labeling alignment.
Solutions like Qredible’s Q-Trust ecosystem are designed for exactly this moment.
Q-Verify helps businesses document and prove regulatory compliance with blockchain-secured verification of products, licenses, and marketing practices.
MyCOA digitizes and secures Certificates of Analysis so you can show, not just claim, that your products meet current standards.
Q-Monitor provides ongoing regulatory and content monitoring, alerting you to issues as rules and enforcement change.
Together, these tools help hemp and cannabis businesses move from reactive compliance to proactive risk management in a landscape where definitions, limits, and enforcement are shifting fast.
To discuss how your organization can prepare for federal hemp THC changes, protect your operations, and maintain trust with regulators, partners, and consumers, reach out to us.
